Tyler Safran & Daniel Juneau. 2023. Radiation Therapy of Benign Diseases. Radiation Therapy of Benign Diseases
89
103
.
Anthony J Hedley. (1973) Long-term aftercare for patients treated for thyrotoxicosis. British Journal of Surgery 60:10, pages 771-774.
Crossref
William R Greig. (1973) Radioactive iodine therapy for thyrotoxicosis. British Journal of Surgery 60:10, pages 758-765.
Crossref
Roger Tell, Göran Lundell, Bo Nilsson, Helena Sjödin, Freddi Lewin & Rolf Lewensohn. (2004) Long-term incidence of hypothyroidism after radiotherapy in patients with head-and-neck cancer. International Journal of Radiation Oncology*Biology*Physics 60:2, pages 395-400.
Crossref
V.P. MICHELANGELI, C. POON, D.J. TOPLISS & P.G. COLMAN. (1995) Specific Effects of Radioiodine Treatment on TSAb and TBAb Levels in Patients with Graves' Disease. Thyroid 5:3, pages 171-176.
Crossref
Gerry H. Tan & Hossein Gharib. (1995) Recurrent Hyperthyroidism After Radioiodine-Induced Hypothyroidism: Report of Two Cases and Literature Review. Endocrine Practice 1:3, pages 158-160.
Crossref
Masako Tsuruta, Yuji Nagayama, Naokata Yokoyama, Motomori Izumi & Shigenobu Nagataki. (1993) Long-term follow-up studies on Iodine-131 treatment of hyperthyroid graves’ disease based on the measurement of thyroid volume by ultrasonography. Annals of Nuclear Medicine 7:3, pages 193-197.
Crossref
David V. Feliciano. (1992) Everything you wanted to know about Graves' disease. The American Journal of Surgery 164:5, pages 403-411.
Crossref
I. Ross McDougallI. Ross McDougall. 1992. Thyroid Disease in Clinical Practice. Thyroid Disease in Clinical Practice
82
162
.
I. Ross McDougallI. Ross McDougall. 1992. Thyroid Disease in Clinical Practice. Thyroid Disease in Clinical Practice
304
324
.
I. Ross McDougall. (1991) Graves' Disease: Current Concepts. Medical Clinics of North America 75:1, pages 79-95.
Crossref
L. J. DeGroot, A. Mangklabruks & M. McCormick. (2014) Comparison of RA 131I treatment protocols for Graves? disease. Journal of Endocrinological Investigation 13:2, pages 111-118.
Crossref
Tanekazu Harada, Makoto Katagiri, Katsutaro Shimaoka & Kunihiko Ito. (1989) A comparative evaluation of the surgical and radioiodine treatments for Graves’ disease. The Japanese Journal of Surgery 19:1, pages 29-37.
Crossref
Henric Blomgren, Björn Petrini, Jerzy Wasserman, Per-Olof Schnell & Göran Lundell. (1987) Changes of the blood lymphocyte population following 131I treatment for nodular goiter. International Journal of Radiation Oncology*Biology*Physics 13:2, pages 209-215.
Crossref
A. W. G. GOOLDEN & J. S. W. STEWART. (2008) LONG‐TERM RESULTS FROM GRADED LOW DOSE RADIOACTIVE IODINE THERAPY FOR THYROTOXICOSIS. Clinical Endocrinology 24:2, pages 217-222.
Crossref
C P Lowdell, G S Spathis, D O Cosgrove, H J Dobbs, V R McCready & C L Harmer. (2016)
Low-Dose
131
I in Treatment of Graves' Disease
. Journal of the Royal Society of Medicine 78:3, pages 197-202.
Crossref
EVA ERIKSSON, KRISTIAN ERIKSSON & PETER WAHLBERG. (2009) Treatment of Hyperthyroidism with Standard Doses of Radioiodine Aiming at Ablation. Acta Medica Scandinavica 217:1, pages 55-60.
Crossref
P. Pfannenstiel. 1985. Progress in radiopharmacology 1985. Progress in radiopharmacology 1985
199
216
.
S.J. Jones, B. Curtis, A.J. Hedley, S.P. Allison, A.M.J. Woolfson, R. Steele, P.D. Bewsher & R.D. Weir. (1982) DO WE NEED THYROID FOLLOW-UP REGISTERS?. The Lancet 319:8283, pages 1229-1233.
Crossref
I. ROSS McDOUGALL. (1981) Treatment of Hyper- and Hypothyroidism. The Journal of Clinical Pharmacology 21:8-9, pages 365-384.
Crossref
ROBERT L. ROSENBAUM & URIEL S. BARZEL. (1981) Clinical Hypothyroidism in the Elderly-A Preventable Disorder?*. Journal of the American Geriatrics Society 29:5, pages 221-223.
Crossref
J.D. Best, V. Chan, R. Khoo, C.S. Teng, C. Wang & R.T.T. Yeung. (1981) Incidence of hypothyroidism after radioactive iodine therapy for thyrotoxicosis in Hong Kong Chinese. Clinical Radiology 32:1, pages 57-61.
Crossref
William H. Beierwaltes. (1979) The history of the use of radioactive iodine. Seminars in Nuclear Medicine 9:3, pages 151-155.
Crossref
B.-A. Lamberg. (1979) 1 Aetiology of hypothyroidism. Clinics in Endocrinology and Metabolism 8:1, pages 3-19.
Crossref
William H. Beierwaltes. (1978) The treatment of hyperthyroidism with iodine-131. Seminars in Nuclear Medicine 8:1, pages 95-103.
Crossref
K. Anger, D. V. Becker, W. Bessler, A. Bischof-Delaloye, W. Börner, A. Churchod, B. Delaloye, H. Emde, U. Feine, W. Finck, M. Friedrich, H. Fritzsche, H. W. Gray, W. R. Greig, K. Hennig, R. Höfer, G. Hör, H. Hundeshagen, E. Krönert, P. Mariß, R. Montz, H. W. Pabst, M. Ramos, F. Ritzl, H. Rösler, K. zum Winkel, F. Wolf, P. Woller, U. Zeidler, E. Zeitler & G. ZitaDavid V. Becker. 1978. Nuklearmedizin / Nuclear Medicine. Nuklearmedizin / Nuclear Medicine
163
174
.
W. J. IRVINE & A. D. TOFT. (1976) THE DIAGNOSIS AND TREATMENT OF THYROTOXICOSIS. Clinical Endocrinology 5:6, pages 687-707.
Crossref
J.F. Malone & M.J. Cullen. (1976) TWO MECHANISMS FOR HYPOTHYROIDISM AFTER 131I THERAPY. The Lancet 308:7976, pages 73-75.
Crossref
G.M. Wilson. (1976) The treatment of thyrotoxicosis by radioiodine. Pharmacology & Therapeutics. Part C: Clinical Pharmacology and Therapeutics 1:1-2, pages 101-118.
Crossref
Peter Weidinger, PhilipM. Johnson & SidneyC. Werner. (1974) FIVE YEARS' EXPERIENCE WITH IODINE-125 THERAPY OF GRAVES' DISEASE. The Lancet 304:7872, pages 74-77.
Crossref
K. W. Wenzel, H. Meinhold, M. Raffenberg, F. Adlkofer & H. Schleusener. (2011)
Classification of Hypothyroidism in Evaluating Patients after Radioiodine Therapy by Serum Cholesterol, T
3
‐Uptake. Total T
4
, FT
4
‐Index, Total T
3
, Basal TSH and TRH‐Test*
. European Journal of Clinical Investigation 4:2, pages 141-148.
Crossref
K. W. Wenzel, H. Meinhold, M. Raffenberg, F. Adlkofer & H. Schleusener. (2008)
Classification of Hypothyroidism in Evaluating Patients after Radioiodine Therapy by Serum Cholesterol, T
3
‐Uptake. Total T
4
, FT
4
‐Index, Total T
3
, Basal TSH and TRH‐Test*
. European Journal of Clinical Investigation 4:1, pages 141-148.
Crossref
Jose L. Cevallos, Garrett A. Hagen, Farahe Maloof & Earle M. Chapman. (1974)
Low-Dosage
131
I Therapy of Thyrotoxicosis (Diffuse Goiters)
. New England Journal of Medicine 290:3, pages 141-143.
Crossref
Hironori Nakajima, Nozomu Sasaki, Norio Kadomura & Hiroo Niimi. (2007)
A Case of Hypothyroidism Probably Caused by
131
I Transmitted in Maternal Milk
. Pediatrics International 15:1, pages 70-72.
Crossref
Ariel Gordin, Gustav Wägar & Carl August Hernberg. (2009) SERUM THYROTROPHIN AND RESPONSE TO THYROTROPHIN-RELEASING HORMONE IN PATIENTS WHO ARE EUTHYROID AFTER RADIOIODINE TREATMENT FOR HYPERTHYROIDISM. Acta Medica Scandinavica 194:1-6, pages 335-340.
Crossref
J. R. McDougall & W. R. Greig. (2016)
Combined Carbimazole-
131
I Treatment for Thyrotoxicosis
. Scottish Medical Journal 17:2, pages 57-61.
Crossref
. (1972) Radioiodine Treatment of Thyrotoxicosis. The Lancet 299:7740, pages 23-25.
Crossref
J. R. McDougall & W. R. Greig. (2016) Pathogenesis and Treatment of Thyrotoxicosis. Scottish Medical Journal 16:12, pages 519-531.
Crossref
Earle M. Chapman. (1971) Which Radioiodine?. New England Journal of Medicine 285:20, pages 1142-1143.
Crossref
David V. Becker & James R. Hurley. (1971) Complications of radioiodine treatment of hyperthyroidism. Seminars in Nuclear Medicine 1:4, pages 442-460.
Crossref
Z. Lewitus, E. Lubin, J. Rechnic, M. Ben-Porath & Y. Feige. (1971) Treatment of thyrotoxicosis with 125I and 131I. Seminars in Nuclear Medicine 1:4, pages 411-421.
Crossref
Alberto Hayek, Earle M. Chapman & John D. Crawford. (1970) Long-Term Results of Treatment of Thyrotoxicosis in Children and Adolescents with Radioactive Iodine. New England Journal of Medicine 283:18, pages 949-953.
Crossref
SidneyC. Werner, PhilipM. Johnson, PaulN. Goodwin, JanD. Wiener & G.A. Lindeboom. (1970) LONG-TERM RESULTS WITH IODINE-125 TREATMENT FOR TOXIC DIFFUSE GOITRE. The Lancet 296:7675, pages 681-685.
Crossref
Luc Campana, Gerhard Hoffmann, Alfons Jakob, Eberhard Kleberger, W. Mehring, Wilhelm Oelssner, Heinz Oeser, G. Pannewitz, Wolf S. Reichel, Julius K. Ries, Eberhard Scherer, E. Ruckensteiner, Werner Schlungbaum & Hermann TrübesteinWerner Schlungbaum. 1970. Spezielle Strahlentherapie Gutartiger Erkrankungen. Spezielle Strahlentherapie Gutartiger Erkrankungen
144
217
.
L. Campana, G. Hoffmann, A. Jakob, E. Kleberger, W. Mehring, W. Oelssner, H. Oeser, G. von Pannewitz, W. S. Reichel, J. K. Ries, E. Scherer, E. Ruckensteiner, W. Schlungbaum & H. TrübesteinWerner Schlungbaum. 1970. Spezielle Strahlentherapie Gutartiger Erkrankungen / Radiation Therapy of Benign Diseases. Spezielle Strahlentherapie Gutartiger Erkrankungen / Radiation Therapy of Benign Diseases
144
217
.
Z. Lewitus. (1969) IODINE-125 TREATMENT FOR THYROTOXICOSIS. The Lancet 294:7634, pages 1368.
Crossref
. (1969) THYROTOXICOSIS: DRUGS, SURGERY, OR RADIOIODINE?. The Lancet 294:7627, pages 944.
Crossref
. (1969) CONTROL OF FOOT-AND-MOUTH DISEASE. The Lancet 294:7627, pages 943-944.
Crossref
Brown M. Dobyns. (1969) Goiter. Current Problems in Surgery 6:1, pages CO1-60.
Crossref
J.R. Philp, MichaelT. Harrison, E.F. Ridley & J. Crooks. (1968) TREATMENT OF THYROTOXICOSIS WITH IONISING RADIATION. The Lancet 292:7582, pages 1307-1310.
Crossref
S. K. Bhatia, D. R. Hadden, D. A. D. Montgomery & J. A. Weaver. (2008) The management of thyrotoxicosis with therapeutic radioiodine. Irish Journal of Medical Science 1:10, pages 449-457.
Crossref
Garrett A. Hagen. (1968) Treatment of Thyrotoxicosis With 131I and Post-therapy Hypothyroidism. Medical Clinics of North America 52:2, pages 417-429.
Crossref
. (1967) A New Look at Radioiodine Therapy of Thyrotoxicosis. New England Journal of Medicine 277:11, pages 596-597.
Crossref
Garrett A. Hagen, Robert P. Ouellette & Earle M. Chapman. (1967)
Comparison of High and Low Dosage Levels of
131
I in the Treatment of Thyrotoxicosis
. New England Journal of Medicine 277:11, pages 559-562.
Crossref
J. S. Penington & F. I. R. Martin. (1967) HYPOTHYROIDISM FOLLOWING TREATMENT OF THYROTOXICOSIS WITH RADIOIODINE. Medical Journal of Australia 2:14, pages 641-643.
Crossref
. (1967) Treatment of Hyperthyroidism. The Lancet 290:7512, pages 406-407.
Crossref
Pincus Taft. (1967) RADIOISOTOPES IN MEDICINE: 3: THE DIAGNOSTIC AND THERAPEUTIC USE OF RADIOACTIVE IODINE IN NON–MALIGNANT THYROID DISEASE. Medical Journal of Australia 1:8, pages 407-410.
Crossref
W. R. Greig. (2016) The Treatment of Thyrotoxicosis with Radioactive Iodine. Scottish Medical Journal 11:9, pages 307-314.
Crossref
J. K. DonovanJ. R. Turtle. (1966) THE RESULTS OF RADIOIODINE THERAPY IN THYROTOXICOSIS. Medical Journal of Australia 2:6, pages 271-272.
Crossref
W R Creig, J Crooks & A G Macgregor. (2016)
Clinical and Radiobiological Consequences of Therapeutic Thyroid Irradiation [
Abridged
]
. Proceedings of the Royal Society of Medicine 59:7, pages 599-602.
Crossref
John T. Dunn & Earle M. Chapman. (1964) Rising Incidence of Hypothyroidism after Radioactive-Iodine Therapy in Thyrotoxicosis. New England Journal of Medicine 271:20, pages 1037-1042.
Crossref
John B. Stanbury & Leslie J. DeGroot. (1964)
Problem of Hypothyroidism after I
131
Therapy of Hyperthyroidism
. New England Journal of Medicine 271:4, pages 195-196.
Crossref